The relation of Graves' ophthalmopathy to circulating thyroid hormone status

被引:21
作者
Kim, JM
LaBree, L
Levin, L
Feldon, SE
机构
[1] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90089 USA
[2] Univ So Calif, Dept Prevent Med Stat Consultat, Los Angeles, CA 90089 USA
[3] Univ So Calif, Res Ctr, Los Angeles, CA 90089 USA
[4] Univ So Calif, Doheny Eye Inst, Los Angeles, CA 90089 USA
关键词
D O I
10.1136/bjo.88.1.72
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aim: The risk factors and epidemiological data for Graves' ophthalmopathy with and without abnormal circulating thyroid levels were examined to determine the relation of thyroid dysfunction to ophthalmopathy. Methods: The authors retrospectively evaluated 482 patients seen with Graves' ophthalmopathy. Of these, 413 were classified as having abnormal levels of circulating thyroid hormone (ALTH) and 69 as having normal levels of circulating thyroid hormone (NLTH). Results: Patients in the NLTH group, compared to the ALTH group, were older on average (56 (SD 13.5) v 52 (15.4)) and had a higher age adjusted body mass index (26.1 (0.8) v 23.4 (0.3)). In addition, a higher percentage of NLTH patients had hypercholesterolaemia. Those in the ALTH group were more likely to be female (76% v 51%), to have a family history of thyroid problems, and to have had eye surgery. Conclusion: NLTH and ALTH appear to differ from each other in terms of risk factors and epidemiological characteristics. Additionally, thyroid dysfunction seems to be associated with a more severe ophthalmopathy compared to the euthyroid state.
引用
收藏
页码:72 / 74
页数:3
相关论文
共 28 条
  • [1] EXOPHTHALMOS IN AUTOIMMUNE THYROID-DISEASE
    AMINO, N
    YUASA, T
    YABU, Y
    MIYAI, K
    KUMAHARA, Y
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (06) : 1232 - 1234
  • [2] LIPID AND LIPOPROTEIN PATTERN IN THYROID-DYSFUNCTION AND THE EFFECT OF THERAPY
    AVIRAM, M
    LUBOSHITZKY, R
    BROOK, JG
    [J]. CLINICAL BIOCHEMISTRY, 1982, 15 (01) : 62 - 66
  • [3] SPECIFIC WEIGHT-LOSS IN HYPER-THYROIDISM
    BRATUSCHMARRAIN, P
    SCHMID, P
    WALDHAUSL, W
    SCHLICK, W
    [J]. HORMONE AND METABOLIC RESEARCH, 1978, 10 (05) : 412 - 415
  • [4] *CDCP, 1998, NAT DIAB FACT SHEET
  • [5] AUTOIMMUNITY IN PATHOGENESIS OF ENDOCRINE EXOPHTHALMOS
    DONIACH, D
    FLORINCHRISTENSEN, A
    [J]. CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1975, 4 (02): : 341 - 350
  • [6] GORMAN CA, 1983, MAYO CLIN PROC, V58, P515
  • [7] PRESENTATION AND MANAGEMENT OF ENDOCRINE OPHTHALMOPATHY
    GORMAN, CA
    [J]. CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1978, 7 (01): : 67 - 96
  • [8] LONG-TERM WEIGHT REGULATION IN TREATED HYPERTHYROID AND HYPOTHYROID SUBJECTS
    HOOGWERF, BJ
    NUTTALL, FQ
    [J]. AMERICAN JOURNAL OF MEDICINE, 1984, 76 (06) : 963 - 970
  • [9] GENETIC-DIFFERENCES SHOWN BY HLA TYPING AMONG JAPANESE PATIENTS WITH EUTHYROID GRAVES OPHTHALMOPATHY, GRAVES-DISEASE AND HASHIMOTO THYROIDITIS - GENETIC-CHARACTERISTICS OF EUTHYROID GRAVES OPHTHALMOPATHY
    INOUE, D
    SATO, K
    MAEDA, M
    INOKO, H
    TSUJI, K
    MORI, T
    IMURA, H
    [J]. CLINICAL ENDOCRINOLOGY, 1991, 34 (01) : 57 - 62
  • [10] STUDIES ON THYROTROPIN RECEPTOR ANTIBODIES IN PATIENTS WITH EUTHYROID GRAVES-DISEASE
    KASAGI, K
    HATABU, H
    TOKUDA, Y
    IIDA, Y
    ENDO, K
    KONISHI, J
    [J]. CLINICAL ENDOCRINOLOGY, 1988, 29 (04) : 357 - 366